Almost three decades have passed since actin-cytoskeleton (acto-myosin comp
lex) was first discovered in non-muscle cells. A combination of cell biolog
y, biochemistry, and molecular biology has revealed the structure and funct
ion of many actin-binding proteins and their physiological role in the regu
lation of cell motility, shape, growth, and malignant transformation. As mo
lecular oncologists, we would like to review how the function of actin-cyto
skeleton is regulated through Ras/Rho family GTPases- or phosphoinositides-
mediated signaling pathways, and how malignant transformation is controlled
by actin/phosphoinositides-binding proteins or drugs that block Rho/Rac/CD
C42 GTPases-mediated signaling pathways. (C) 1999 Wiley-Liss, Inc.